[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1990

Surgical Aspects of Sclerosing Encapsulating Peritonitis

Author Affiliations

From the Department of Surgery, Francis Scott Key Medical Center, The Johns Hopkins University School of Medicine, Baltimore, Md (Drs Kittur, Raytch, and Smith); and the Shrikhande Clinic, Bombay, India (Dr Korpe).

Arch Surg. 1990;125(12):1626-1628. doi:10.1001/archsurg.1990.01410240108022
Abstract

• Sclerosing encapsulating peritonitis (SEP) is associated with the administration of beta-blocking agents as well as continuous ambulatory peritoneal dialysis. The predisposing factors in the latter group are recurrent peritonitis, presence of acetate in the dialysate, and antiseptics used during bag exchanges. We report a case of SEP following chronic ambulatory peritoneal dialysis and review the literature on this benign yet potentially lethal condition. Sclerosing encapsulating peritonitis frequently leads to intestinal obstruction, small-bowel necrosis, enterocutaneous fistulas, and malnutrition. There is a high incidence of anastomotic failure when a resection and primary intestinal anastomosis is performed in patients with SEP. Although SEP is not commonly reported in the surgical literature, its importance to surgeons is indicated by the fact that the overall mortality rate is close to 60% in patients with SEP who develop surgical complications.

(Arch Surg. 1990;125:1626-1628)

×